165 related articles for article (PubMed ID: 12083335)
1. Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during L-ornithine-L-aspartate treatment--results of a pilot study.
Delcker A; Turowski B; Mihm U; Raab P; Rusch O; Pilatus U; Zeuzem S; Zanella FE
Metab Brain Dis; 2002 Jun; 17(2):103-11. PubMed ID: 12083335
[TBL] [Abstract][Full Text] [Related]
2. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
[TBL] [Abstract][Full Text] [Related]
3. Low visual cortex GABA levels in hepatic encephalopathy: links to blood ammonia, critical flicker frequency, and brain osmolytes.
Oeltzschner G; Butz M; Baumgarten TJ; Hoogenboom N; Wittsack HJ; Schnitzler A
Metab Brain Dis; 2015 Dec; 30(6):1429-38. PubMed ID: 26359122
[TBL] [Abstract][Full Text] [Related]
4. Proton MR spectroscopic measurement of neurometabolites in hepatic encephalopathy during oral lactulose therapy.
Haseler LJ; Sibbitt WL; Mojtahedzadeh HN; Reddy S; Agarwal VP; McCarthy DM
AJNR Am J Neuroradiol; 1998 Oct; 19(9):1681-6. PubMed ID: 9802491
[TBL] [Abstract][Full Text] [Related]
5. Covert hepatic encephalopathy: elevated total glutathione and absence of brain water content changes.
Oeltzschner G; Butz M; Wickrath F; Wittsack HJ; Schnitzler A
Metab Brain Dis; 2016 Jun; 31(3):517-27. PubMed ID: 26563124
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
7. L-ornithine vs. L-ornithine-L-aspartate as a treatment for hyperammonemia-induced encephalopathy in rats.
Vogels BA; Karlsen OT; Mass MA; Boveé WM; Chamuleau RA
J Hepatol; 1997 Jan; 26(1):174-82. PubMed ID: 9148009
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.
Blanco Vela CI; Poo Ramírez JL
Ann Hepatol; 2011 Jun; 10 Suppl 2():S55-9. PubMed ID: 22228883
[TBL] [Abstract][Full Text] [Related]
9. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
[TBL] [Abstract][Full Text] [Related]
10. A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy.
Grover VP; McPhail MJ; Wylezinska-Arridge M; Crossey MM; Fitzpatrick JA; Southern L; Saxby BK; Cook NA; Cox IJ; Waldman AD; Dhanjal NS; Bak-Bol A; Williams R; Morgan MY; Taylor-Robinson SD
Metab Brain Dis; 2017 Feb; 32(1):77-86. PubMed ID: 27488112
[TBL] [Abstract][Full Text] [Related]
11. Roles of Glutamate and Glutamine Transport in Ammonia Neurotoxicity: State of the Art and Question Marks.
Dabrowska K; Skowronska K; Popek M; Obara-Michlewska M; Albrecht J; Zielinska M
Endocr Metab Immune Disord Drug Targets; 2018; 18(4):306-315. PubMed ID: 29256360
[TBL] [Abstract][Full Text] [Related]
12. Hepatic encephalopathy: a neurochemical, neuroanatomical, and neuropsychological study.
Binesh N; Huda A; Thomas MA; Wyckoff N; Bugbee M; Han S; Rasgon N; Davanzo P; Sayre J; Guze B; Martin P; Fawzy F
J Appl Clin Med Phys; 2006; 7(1):86-96. PubMed ID: 16518320
[TBL] [Abstract][Full Text] [Related]
13. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
14. Multi-dimensional MR spectroscopy: towards a better understanding of hepatic encephalopathy.
Sarma MK; Huda A; Nagarajan R; Hinkin CH; Wilson N; Gupta RK; Frias-Martinez E; Sayre J; Guze B; Han SH; Thomas MA
Metab Brain Dis; 2011 Sep; 26(3):173-84. PubMed ID: 21698453
[TBL] [Abstract][Full Text] [Related]
15. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.
Stauch S; Kircheis G; Adler G; Beckh K; Ditschuneit H; Görtelmeyer R; Hendricks R; Heuser A; Karoff C; Malfertheiner P; Mayer D; Rösch W; Steffens J
J Hepatol; 1998 May; 28(5):856-64. PubMed ID: 9625322
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy.
Kircheis G; Lüth S
Drugs; 2019 Feb; 79(Suppl 1):23-29. PubMed ID: 30706424
[TBL] [Abstract][Full Text] [Related]
17. MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation.
Naegele T; Grodd W; Viebahn R; Seeger U; Klose U; Seitz D; Kaiser S; Mader I; Mayer J; Lauchart W; Gregor M; Voigt K
Radiology; 2000 Sep; 216(3):683-91. PubMed ID: 10966695
[TBL] [Abstract][Full Text] [Related]
18. Creatine supplementation lowers brain glutamate levels in Huntington's disease.
Bender A; Auer DP; Merl T; Reilmann R; Saemann P; Yassouridis A; Bender J; Weindl A; Dose M; Gasser T; Klopstock T
J Neurol; 2005 Jan; 252(1):36-41. PubMed ID: 15672208
[TBL] [Abstract][Full Text] [Related]
19. In vivo proton magnetic resonance spectroscopy for the evaluation of hepatic encephalopathy in dogs.
Carrera I; Kircher PR; Meier D; Richter H; Beckman K; Dennler M
Am J Vet Res; 2014 Sep; 75(9):818-27. PubMed ID: 25157885
[TBL] [Abstract][Full Text] [Related]
20. Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis.
Rovira A; Grivé E; Pedraza S; Rovira A; Alonso J
AJNR Am J Neuroradiol; 2001; 22(6):1137-42. PubMed ID: 11415910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
